Phase III bioequivalence trial of buprenorphine/naloxone sublingual spray versus buprenorphine/naloxone sublingual film (Suboxone®).
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2014
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine/naloxone
- Indications Opioid abuse
- Focus Pharmacokinetics; Registrational
- Sponsors INSYS Therapeutics, Inc
- 03 Dec 2014 New trial record
- 11 Nov 2014 Insys Therapeutics plans to initiate this pivotal trial in 2015, according to a company media release.